Cautious attitude of domestic drug makers required for successful co-promotion with foreign partners

Amid the increasing trend of co-promotion agreements between the Korean pharmaceutical firms and foreign counterparts, market experts have recommended that domestic pharmaceutical firms need to be more cautious of the possible business failure due mainly to different expectation of both sides, although the old-product transfer of multinational firms is positive in terms of mutual collaboration ...